Sino-Swedish Biomedicine seminar held in Uppsala

By Xuefei Chen Axelsson

STOCKHOLM, Sept. 21(Greenpost)– Changsha National High-tech Industrial Development Zone delegation held a seminar with Research Institute of Sweden and Uppsala Bio on Thursday in Uppsala to discuss cooperation in biomedicine.

The seminar was presided over by Zhao Shouting, Nordic Chinese Sustainable Development Association.

Song Jie,  deputy director of  the Changsha National High-tech Industrial Development Zone delegation gave a brief introduction about his zone.

“CNHDZ is Hunan Province’s Silicon Valley and ranks top 10 in innovation capability. We have issued a new policy to encourage more overseas enterprises and talented people to open businesses in the zone. ”

Song said the grants can be as high as twenty million yuan every year and the total is 100 million per year.

The zone is very strong in biomedicine and really likes to cooperate with Swedish counterparts.

He said Changsha was the place that raised the first artificial baby and held the largest frozen sperm bank.

He welcomes Swedish companies to cooperate with their counterparts.  He promised that the government is just willing to provide a platform for enterprises to cooperate.

Johan Laurell gave a brief introduction about Research Institutes of Sweden or RISE. He is the marketing manager.

He said RISE includes a lot of industries including food and medicine and plays a role of helping enterprises to find their international partners.

Erik Forsberg from Uppsala Bio introduced his company which is a very famous Swedish biomedicine company.

The famous Pfizer company used to be part of it.  Forsberg said it is good to understand what kind of cooperation model will be and will bring more relevant companies to meet next time.

Jan Peter Axelsson used to work in Pfizer and now in Vascaia also introduced his company, his colleague and his own expertise. He is good at providing automatic and efficient  production method.

Zhou Wenqiang is Chief Scientist from Hunan Fangsheng Pharmaceutical Co. Ltd

Hao Zou is General Manager from Hunan Hua Rui Biological Technology Co. Ltd.

Huang Qingxi is from Central Bio-MD Valley Technology Co. Ltd

Guo Xialing is Board Chairman of Argus (Hunan) Pharmaceutical Ltd.  She said she is looking for experts in fermentation.

The two sides also discussed partnerships, cooperation model, platforms and mechanisms to deepen the cooperation between the two sides.

Photo and Text:  Xuefei Chen Axelsson

今日头条:长沙高新区瑞典生物医药论坛在乌普萨拉举行

北欧绿色邮报网报道(记者陈雪霏)–  湖南长沙高新区代表团成员21日在瑞典大学城也是最古老的城市乌普萨拉与瑞典研究院和乌普萨拉生物医药公司举行中瑞生物医药论坛。

北欧中国可持续发展协会会长张寿廷主持论坛会议。

长沙高新区调研员,主任助理宋捷受新区管委会副主任陈志红委托在开幕式上简要介绍了长沙高新区的有关情况。

他说,长沙高新区素有湖南的硅谷美誉是中国首批国家高新技术产业开发区,科技创新能力进入全国10强。2016年出台了长沙高新区促进生物医药与健康产业发展实施意见,设立10亿元生物医药与健康产业发展专项资金,从促进企业做大做强,支持公共服务平台建设,加强高端人才引进等方面支持产业发展。高新区还设立了侨梦苑建设专项资金,每年安排一亿元,对包括旅欧华人在内的华人华侨和海归创新创业项目最高给予2000万元的资金支持,并在厂房补贴,人才公寓,技术研发等方面给予重点支持。

“我们热忱欢迎北欧的企业界朋友和各位生命科学领域高端人才到长沙考察指导,洽谈合作,投资兴业。”

瑞典研究院市场部经理约翰. 劳莱尔向大家介绍了瑞典研究院的情况。他说,瑞典研究院是瑞典各行各业联合在一起的标准制定单位。它包括农业,医药和食品行业,生物制药行业,材料等多种行业的质量标准制定和监管部门。这个部门也是帮助瑞典企业实现国际合作,走出国门与跨国公司合作的部门,因此,他非常高兴能有机会参加这个论坛与中国公司见面。

乌普萨拉生物医药产业园总经理埃里克.佛斯伯格说,乌普萨拉生物医药产业园于1984年建立,曾经有辉煌的历史,以前瑞典最著名的Pharmacia就是属于这里的,但是,公司后来分裂成通用健康产业公司,辉瑞制药公司和其他几个公司。

目前它依然有很多中小企业,其宗旨就是帮助中小企业与外界合作寻找合作伙伴。他希望通过本次论坛能够了解中国公司的需求,了解中方的合作模式,希望下次来能带新的公司来与中国公司对接。

随后,湖南华瑞达生物科技有限公司总经理邹豪介绍了他的公司。

中部生物谷科技有限公司董事长黄庆玺介绍了其公司的运营模式,仿佛是阿里巴巴,是医药方面的阿里巴巴。

湖南方盛制药股份有限公司首席科学家周文强介绍他的公司。

大邦生物制药有限公司董事长郭霞凌介绍了自己的生物制药公司。

瑞典Vascaia公司的雅克塞尔松介绍了他曾在辉瑞制药和目前公司的经历和技术。他利用电脑进行自动化生产方式的优化。

最后,双方就合作模式,合作平台,合作对象进行了详细讨论和沟通,增进了相互了解,为今后进一步合作打下了基础。

茶歇期间,大家还为代表团的胡斌过了生日,品尝了瑞典著名的公主蛋糕。

昨天,代表团进行了瑞典生物制药招商引智推介会。明天还将参观瑞典制药厂。

图文/陈雪霏

 

SCEA Helps Guangzhou Media Delegation Visit Nobel’s Hometown

By Xuefei Chen Axelsson

STOCKHOLM, Sept. 20(Greenpost) – A group of shooting crew from Guangzhou Media Delegation has interviewed Maria Masucci, Vice Chancellor of Karolinska Institutet and Ingmar Enberg, Professor in Infection and Cancer on Wednesday.

The delegation TV crew interviewed Vice Chancellor Maria Masucci at her office in the new Aula building beside the old buildings. The spectacular building itself is already a great scene worthy of an intensive examination.

When she was asked about why Karolinska Institutet was chosen to issue Nobel Prize in Physiology or Medicine, Masucci said it was Alfred Nobel’s will to give this task to KI. At the beginning it was all the professors who participated in the Nobel Assembly, but later it was limited to 50 professors even though KI now has over 400 professors.

Talking about her experience of contacting with China, Masucci said that she still remember the first Chinese student who studied at Karolinska Institutet in the 1970s.  Now over 400 Chinese PhDs and Masters  have graduated from Karolinska Institutet. And more and more Chinese students are coming to study at KI.

She spoke highly of the progress made in Medical science in China and she gave the credits to the Chinese leaders who have great ambitions in science and technology progress.

“I think the Chinese government has been very wise to invest more in scientific research. It has been fantastic happening and a lot of progress has been made and a lot of students have been trained in China,” said Masucci.

She said she has been to China many times and even stayed in Guangzhou for a month long time ago.

Talking about innovation in KI, Masucci said that they have been trying to be innovative both in terms of teaching and in terms of research which was done always based on evidence.

She also mentioned Chinese medicine research in collaboration with KI.

The media crew also interviewed Professor Ingmar Enberg who is an expert in man’s infection and cancer at KI.

He said he had been contacting China for over 40 years and due to his great efforts, he was awarded as Ambassador between China and Sweden。

“Now China and Sweden cooperate more closely and mutually while in the 1970s, it was really a relation between a developed country and a developing country. China has seen great progress since mid 1990s due to the overseas students going back to China.”

Enberg said KI has taught over 400 Chinese PhDs and Masters and two thirds of them went back to China to contribute to Chinese medical sciences.

KI is a university that does research on the one side and the other side is KI hospital. So the research and clinic has close connection.

The delegation also visited Nobel Forum and the KI campus and they all felt impressed by the visit.

Luna Zhang, Executive Director and General Manager of Rongtai Investment AB and Lifu Hu, tumour expert at Karolinska Institutet accompanied the Guangzhou Media delegation to visit Karolinska Institutet and arranged the interviews.

Photo and Text by Xuefei Chen Axelsson